U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 2 of 2 results

CEFOTETAN

MORE DETAILS

  48SPP0PA9Q

Status:
US Approved Rx (2007)
First approved in 1985
Class (Stereo):
CHEMICAL (EPIMERIC-AXIAL)
Targets:
Bacterial penicillin-binding protein
233
Conditions:
Urinary tract infections
205
Intra-abdominal infections
49
Skin and skin structure infections
80
Bone and joint infections
27
Lower respiratory tract infections
51
Gynecologic infections
18
Cefotetan is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positi...

CEFOTETAN DISODIUM

MORE DETAILS

  0GXP746VXB

Status:
US Approved Rx (2007)
First approved in 1985
Class (Stereo):
CHEMICAL (EPIMERIC)
Targets:
Bacterial penicillin-binding protein
233
Conditions:
Urinary tract infections
205
Intra-abdominal infections
49
Skin and skin structure infections
80
Bone and joint infections
27
Lower respiratory tract infections
51
Gynecologic infections
18
Cefotetan is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positi...
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966